Decreased tumorigenicity of a transplantable rat sarcoma following transfer and expression of an IL‐2 cDNA
- 21 January 1991
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 47 (2) , 244-251
- https://doi.org/10.1002/ijc.2910470213
Abstract
The notion that tumour-cell-derived IL-2 might lead to paracrine stimulation of the host anti-tumour response was tested in a transplantable rat sarcoma model. Three HSNLV clones induced to secrete different amounts of human IL-2 following retroviral gene transfer showed reduced tumorige-nicity and metastatic potential in athymic (nu/nu) and immunocompetent syngeneic rats which was directly related to the level of IL-2 secretion. In contrast, the tumorigenicity of HSNLV clones secreting a biologically inactive form of IL-2 (IL-2Lys20) was unaltered. T-lymphocyte-mediated rejection of Zip I, the highest IL-2 producer, was demonstrated histologically in hooded rats and infiltrating mononuclear cells were also observed in Zip I tumours growing in athymic rats. Tumours derived from IL-2-secreting HSNLV showed reduced or absent IL-2 secretion in immunocompetent rats, sometimes with associated loss of the IL-2 provirus, but continued to secrete IL-2 in nude rats. The host response to Moloney-helper-virus-infected HSNLV was also examined and the results represent a cautionary note to those undertaking experiments of a similar nature.Keywords
This publication has 28 references indexed in Scilit:
- Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor responseCell, 1990
- Lymphokine gene therapy for cancerImmunology Today, 1990
- Mechanism of Interleukin-2 Signaling: Mediation of Different Outcomes by a Single Receptor and Transduction PathwayScience, 1989
- The bimolecular structure of the interleukin 2 receptorImmunology Today, 1988
- Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic MelanomaNew England Journal of Medicine, 1988
- Interleukin-2: Inception, Impact, and ImplicationsScience, 1988
- The IL-2 Receptor β Chain (p70): Role in Mediating Signals for LAK, NK, and Proliferative ActivitiesScience, 1987
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- TECHNOLOGICAL EXAMINATION OF LOW‐FIRED TERRACOTTA STATUES FROM AYIA IRINI, KEAArchaeometry, 1982
- A new dominant hybrid selective marker for higher eukaryotic cellsJournal of Molecular Biology, 1981